METTL3-based epitranscriptomic editing screening identifies functional m6A sites in cancers [ATAC-Seq]
To investigate the molecular role of CHD9 in prostate cancer, we knockdown CHD9 gene by two different shRNAs in 22Rv1 cells. Overall design: Differential gene expression analysis of RNA-seq data for KD control cells and KD CHD9 cells